Noble Hospital

At the Noble Hospital Comprehensive Breast Program, we strive for personal care with the most advanced technology being offered in Western Massachusetts. We will see patients within 24-48 hours of a newly diagnosed cancer or exam with suspicious findings.  Biopsies can be performed on the same day of your consultation.  We will assist you and your family through the process. Our priority is you!

The Comprehensive Breast Program at Noble Hospital is led by Dr. Steven Schonholz, FACS, a highly–regarded Breast Surgeon who is part of a very talented team.  The Comprehensive Breast Program at Noble Hospital provides women of all ages with a full range of diagnostic and treatment options for breast–related care.  The Program utilizes the latest diagnostic technology and procedures from a single, easy-to-access location.  Services include imaging, diagnosis, surgical and nonsurgical treatments, breast reconstruction, and medical oncology.

These services are designed to assist a woman from initial symptoms or abnormalities through the entire treatment process. Some of our newest leading treatment options include:

Identifying And Assessing High-Risk Patients

Minimally Invasive Lumpectomies

Screening For Lymphedema

Accelerated Partial Breast Irradiation

In-Office Ultrasound And Mammographic Stereographic Biopsies

Survivorship Program - "The Pink W.A.Y."

Burk Women's Center

Watch Dr. Schonholz talk about cancer treatment options on 22News' Mass Appeal:

New breast cancer treatments available at Noble Hospital


A Strong Foundation

Board-certified Radiologists at the Burk Women’s Center are part of the accredited program for mammography featuring the latest diagnostic equipment for the early detection of breast cancer. Follow-up procedures include stereotactic biopsies and needle localization, which minimizes discomfort for patients without sacrificing accuracy.

 

Learn About Our Technology Providers

BRCA Testing - Myriad Genetics

Subclinical Lymphedema Evaluation - Impedimed

High Risk Assessment - Brevagen

Genetic Testing of Future Risk - Agendia

APBI - Cianna Medical